SCHEMBL23994454

SCHEMBL23994454

O=c1[nH]cc(-c2cc(N3CC4CCCC4C3)c3nccn3n2)c(=O)[nH]1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 4/20 0.37
▸ CCNE1 P24864 2/20 0.32
▸ CDK2 P24941 2/20 0.32
▸ IP6K1 Q92551 2/20 0.32
▸ IP6K3 Q96PC2 2/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ CDK4 P11802 1/20 0.32
▸ CCNB1 P14635 1/20 0.32
▸ CCNA2 P20248 1/20 0.32
▸ CCND1 P24385 1/20 0.32
▸ CDK9 P50750 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ SYK P43405 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ RAF1 P04049 3/20 0.30
▸ BRAF P15056 3/20 0.30
▸ IP6K2 Q9UHH9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23993292 1.00 NT5E (0.37) NT5ECCNE1CDK2IP6K1IP6K3
SCHEMBL23993788 0.97 NT5E (0.36) NT5ECCNE1CDK2CCNT1CDK1
SCHEMBL23994834 0.96 NT5E (0.38) NT5ECCNE1CDK2CCNT1CDK1
SCHEMBL23994833 0.96 NT5E (0.38) NT5ECCNE1CDK2CCNT1CDK1
SCHEMBL23995425 0.93 NT5E (0.37) NT5ECCNE1CDK2CCNT1CDK1
SCHEMBL23993300 0.92 NT5E (0.40) NT5EMAPTKDM4CSYKALDH1A1
SCHEMBL23995196 0.90 NT5E (0.36) NT5EIP6K1IP6K3RAF1BRAF
SCHEMBL23994921 0.88 NT5E (0.39) NT5ECCNE1CDK2ALDH1A1RAF1
SCHEMBL25004418 0.88 NT5E (0.40) NT5ESYKALDH1A1RAF1BRAF
SCHEMBL23994932 0.88 NT5E (0.40) NT5EMAPTKDM4CALDH1A1RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222522-A1 CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 2021-11-04 — — WO disclosed
Send feedback